Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervix Carcinoma Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00003135
What this trial is testing

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+1 more
The University of Texas Health Science Center, Houston 34
Testing effectiveness (Phase 2)Study completedNCT03438396
What this trial is testing

A Trial of Tisotumab Vedotin in Cervical Cancer

Who this might be right for
Cervical Cancer
Seagen Inc. 102
Testing effectiveness (Phase 2)UnknownNCT00462397
What this trial is testing

Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Who this might be right for
Cervical Cancer
University College London Hospitals 50
Testing effectiveness (Phase 2)Looking for participantsNCT07424664
What this trial is testing

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Who this might be right for
Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Study completedNCT02128126
What this trial is testing

Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
ISA Pharmaceuticals 93
Early research (Phase 1)Active Not RecruitingNCT05527184
What this trial is testing

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Who this might be right for
Endometrial CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+2 more
AbbVie 256
Testing effectiveness (Phase 2)UnknownNCT03340376
What this trial is testing

Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Universitaire Ziekenhuizen KU Leuven 48
Large-scale testing (Phase 3)Study completedNCT03556839
What this trial is testing

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

Who this might be right for
Carcinoma of the Cervix, Stage IVB
Grupo Español de Investigación en Cáncer de Ovario 410
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Not applicableUnknownNCT05883670
What this trial is testing

Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer
Shandong University 118
Testing effectiveness (Phase 2)UnknownNCT01117402
What this trial is testing

Tomotherapy in Postsurgery Recurrent Carcinoma Cervix

Who this might be right for
Postsurgery Recurrent Carcinoma Cervix
Tata Memorial Hospital 90
Not applicableUnknownNCT01710085
What this trial is testing

Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients

Who this might be right for
Cervical CancerEndometrial Cancer
Uludag University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT06238635
What this trial is testing

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Who this might be right for
Cervical CancerAdvanced Cervical CarcinomaMetastatic Cervical Cancer+2 more
Meghan Shea 66
Testing effectiveness (Phase 2)UnknownNCT05444374
What this trial is testing

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Sichuan Cancer Hospital and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT00031759
What this trial is testing

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

Who this might be right for
Cervical CancerPrecancerous Condition
Alliance for Clinical Trials in Oncology 57
Not applicableNot Yet RecruitingNCT07266350
What this trial is testing

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer MetastaticCervical Cancer Recurrent
Qi Zhou 1,300
Testing effectiveness (Phase 2)UnknownNCT00997009
What this trial is testing

Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
National Cancer Institute, Naples 108
Not applicableLooking for participantsNCT07214584
What this trial is testing

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Who this might be right for
Cervical CancerHuman Papilloma Virus (HPV)
University of Florida 55
Next Page